A rotavirus vaccine for infants prevented rotavirus gastroenteritis with no increase in risk of intussusception
- PMID: 17430849
A rotavirus vaccine for infants prevented rotavirus gastroenteritis with no increase in risk of intussusception
Comment on
-
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.N Engl J Med. 2006 Jan 5;354(1):23-33. doi: 10.1056/NEJMoa052664. N Engl J Med. 2006. PMID: 16394299 Clinical Trial.
Similar articles
-
Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.Pediatr Infect Dis J. 2007 Dec;26(12):1099-104. doi: 10.1097/INF.0b013e31814521cb. Pediatr Infect Dis J. 2007. PMID: 18043445 Clinical Trial.
-
A rotavirus vaccine for infants prevented rotavirus gastroenteritis with no increase in risk of intussusception.Evid Based Med. 2006 Aug;11(4):113. doi: 10.1136/ebm.11.4.113. Evid Based Med. 2006. PMID: 17213126 No abstract available.
-
Rotavirus live, oral, pentavalent vaccine.Clin Ther. 2007 Dec;29(12):2724-37. doi: 10.1016/j.clinthera.2007.12.018. Clin Ther. 2007. PMID: 18201590 Review.
-
The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.Int J Infect Dis. 2007 Nov;11 Suppl 2:S36-42. doi: 10.1016/S1201-9712(07)60020-4. Int J Infect Dis. 2007. PMID: 18162245 Clinical Trial.
-
RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.Expert Rev Vaccines. 2008 Dec;7(10):1475-80. doi: 10.1586/14760584.7.10.1475. Expert Rev Vaccines. 2008. PMID: 19053204 Review.
Publication types
LinkOut - more resources
Full Text Sources